News On Japan

Japan Advances iPS Cell Technology with New Osaka Facility

OSAKA, Mar 20 (News On Japan) - A new facility for the research and production of induced pluripotent stem (iPS) cells has been completed in Osaka's Nakanoshima district and was unveiled to the press on March 19th.

Named "Yanai My iPS," the facility was established with a donation from Tadashi Yanai, CEO of Fast Retailing, the company behind Uniqlo and GU. iPS cells, which can transform into various types of cells, are seen as key to regenerative medicine. Currently, they are primarily derived from donor cells, which carries the risk of immune rejection. However, using a patient’s own cells could significantly reduce this risk.

The facility is focusing on developing technology for autologous iPS cells, which are created from a patient’s own tissues. Traditionally, producing iPS cells required manual labor, pushing costs into the tens of millions of yen. However, the new facility aims to provide autologous iPS cells to research institutions for about 1 million yen by the end of this year. The ultimate goal is to begin clinical trials for human treatment by 2028.

iPS cells are reprogrammed from adult cells, such as skin or blood cells, into a pluripotent state, allowing them to transform into almost any cell type. This breakthrough has opened new possibilities for regenerative medicine, offering potential treatments for diseases such as Parkinson’s and macular degeneration while avoiding the ethical concerns associated with embryonic stem cells.

Japan’s government has invested heavily in iPS cell research through institutions like the Center for iPS Cell Research and Application (CiRA) at Kyoto University, led by Yamanaka. Public and private sectors have collaborated to accelerate clinical applications, with several groundbreaking trials already conducted. In 2014, Japan carried out the world’s first iPS cell transplant for macular degeneration. In 2020, iPS-derived cells were tested as a treatment for Parkinson’s disease, showing early promise. More recently, researchers have explored using iPS cells to generate lab-grown blood for transfusions and potential therapies for heart and liver conditions.

A major challenge in iPS research has been the high cost of production, with patient-specific iPS cells initially costing tens of millions of yen. Recent efforts aim to reduce costs and develop mass production systems, making iPS treatments more widely accessible. New facilities, such as the recently opened Yanai My iPS center in Osaka, are working to lower production costs and pave the way for clinical use, with human trials expected in the coming years.

Source: Television OSAKA NEWS

News On Japan
POPULAR NEWS

The Japanese government will begin issuing blue tickets for bicycle traffic violations in April 2026, with fines including 5,000 yen for ignoring stop signs and up to 12,000 yen for riding while using a smartphone.

A 26-year-old woman was arrested in the early hours of April 24th in Kasuya Town, Fukuoka Prefecture, on suspicion of driving under the influence of alcohol. While admitting to the offense, she claimed, "I ate chocolate that contained alcohol."

A man found wandering naked in Saitama Prefecture has been arrested after a string of violent incidents, including a fatal hit-and-run and an attempted abduction, unfolded within roughly 90 minutes on April 21st.

The total number of visitors to Expo 2025 Osaka, Kansai surpassed one million on April 23rd, just 11 days after the event began. Despite being a weekday, the venue remained crowded, with long lines forming at popular pavilions such as the one from the United States.

At the Shanghai Motor Show, which opened to the press on April 23rd ahead of its public run from April 27th to May 2nd, Toyota Motor Corporation revealed a series of new models, including a new electric vehicle, as it works to regain ground in the increasingly competitive Chinese market.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

Kyoto University and its research team have revealed that several former employees of Daikin Industries developed lung diseases, potentially linked to exposure to PFAS (per- and polyfluoroalkyl substances), a group of chemical compounds used in industrial manufacturing.

Amazon held a product briefing for its security brand "Ring" in Fukuoka City on April 21st, aiming to boost recognition in Fukuoka Prefecture, where the population continues to grow.

Japanese astronaut Takuya Onishi has been appointed commander of the International Space Station (ISS), becoming the third Japanese to assume the role.

A new treatment for Parkinson's disease using iPS cells developed by Kyoto University has shown a certain level of effectiveness in clinical trials.

Concerns are mounting over the discovery of illegal radio signals believed to originate from "fake base stations" mimicking cell towers in Tokyo and Osaka, with experts warning of the risk of personal data theft and potential fraud.

Pelvic organ prolapse is a condition affecting a significant number of women over the age of 40, yet remains largely under-recognized. It occurs when organs in the pelvic region, such as the bladder or uterus, descend due to weakened support muscles, often as a result of childbirth or aging.

As the new school term begins, a concerning trend is emerging with whooping cough—caused by the Bordetella pertussis bacterium—spreading across Japan and posing a potentially life-threatening risk, especially to infants who may suffer severe complications or even death from persistent coughing fits.

A new treatment using iPS cells, known for their ability to transform into any type of cell in the body, is poised to become the first of its kind in the world. A venture from Osaka University has applied to the Ministry of Health, Labor and Welfare for approval to manufacture and market the innovative therapy.